COSCIENS Biopharma Reveals Mid-Year Financials
Company Announcements

COSCIENS Biopharma Reveals Mid-Year Financials

COSCIENS Biopharma (TSE:CSCI) has released an update.

COSCIENS Biopharma Inc. has reported a significant increase in total assets, rising to $50,045 thousand as of June 30, 2024, from $23,745 thousand at the end of the previous year. The financial statements also show a comprehensive loss, with retained earnings dropping to $1,533 thousand and an accumulated other comprehensive loss of $1,218 thousand. These interim results highlight the company’s current financial position and performance over the first half of the year.

For further insights into TSE:CSCI stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskCOSCIENS Biopharma Restructures Board After Resignation
TheFlyCosciens Biopharma director Carolyn Egbert resigns
TipRanks Auto-Generated NewsdeskCOSCIENS Biopharma Welcomes New Board Director
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App